Immunization - Adult Immunization News

• Prolonged Delay in Care Impacts Burden of Noma Disease Noma, a gangrenous infection of the face, may go untreated for well over a decade, reflecting the incidence and prevalence of the disease and the ability of existing surgical care systems to provide treatment, researchers say.
  Reuters Health Information, April 2018
• WHO Recommends Testing Before Use of Sanofi's Dengue Vaccine The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.
  Reuters Health Information, April 2018
• Miami Among Cities at Risk From Yellow Fever Spread - Study Miami is at risk of a deadly yellow fever outbreak because the disease could thrive there but the city has no checks on travelers arriving from endemic zones, a study published by the World Health Organization showed.
  Reuters Health Information, April 2018
• GE Rides Gene Therapy Wave With Ready-made Viral Drug Factories General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell therapies, novel anti-cancer treatments and vaccines.
  Reuters Health Information, April 2018
• ACIP Recommends Heplisav-B Vaccine for Adults Heplisav-B, a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on Immunization Practices.
  Medscape Medical News, April 2018
• FDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research The Food and Drug Administration rarely prosecutes research violations, but its criminal division is looking into the experimental herpes vaccine research by Southern Illinois University professor William Halford.
  Kaiser Health News, April 2018
• New GSK Shingles Vaccine Off to Strong Start in Key U.S. Market GlaxoSmithKline's new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90 percent U.S. market share just five months after its launch, prescription-tracking data show.
  Reuters Health Information, April 2018
• Pakistan Launches Countrywide Polio Eradication Drive Pakistan launched a nationwide polio vaccination drive on Monday to try to reach 38.7 million children and eradicate the paralyzing and potentially deadly virus in one of the last countries where it is endemic.
  Reuters Health Information, April 2018
• Single Quadrivalent Flu Shot in IBD Patients In adults with inflammatory bowel disease (IBD), a single dose of quadrivalent inactivated influenza vaccine (QIV) appears to convey adequate immunogenicity, though some immunosuppressants might lessen the effect, according to new research.
  Reuters Health Information, April 2018
• Almost 300 Million Worldwide May Be Infected With HBV About 292 million people worldwide may be infected with hepatitis B virus (HBV), a new modeling study shows.
  Reuters Health Information, April 2018
• Zika Vaccine Strategy Could Eliminate Prenatal Infections A moderately to highly effective Zika-virus vaccine administered to 90% of women of reproductive age could virtually eliminate prenatal infections, researchers say.
  Reuters Health Information, April 2018
• HPV Vaccine Coverage on the Rise, but Still Far From 2020 Goal The proportion of boys and young men in the U.S. receiving the human papillomavirus (HPV) vaccine has more than tripled since 2011, new research shows.
  Reuters Health Information, March 2018
• Single-Dose Oral Cholera Vaccine Protects Older Children, Adults A single-dose regimen of inactivated whole-cell oral cholera vaccine protects adults and children over 5 from infection for at least two years, according to a randomized trial conducted in Bangladesh.
  Reuters Health Information, March 2018
• Cervical Cancer to Double Across Middle East Without Vaccines Deaths from cervical cancer will double in the Middle East and North Africa by 2035 unless conservative nations vaccinate young women and tackle sexual taboos.
  Reuters Health Information, March 2018
• Alert Shingrix Approved in Europe and Japan for Prevention of Shingles In clinical testing, Shingrix demonstrated over 90% efficacy against herpes zoster in adults aged 50 years or older, with efficacy sustained during the 4-year follow-up period.
  International Approvals, March 2018
• Research Misconduct Allegations Shadow New CDC Head The Trump administration yesterday announced that HIV expert Robert Redfield will lead the Centers for Disease Control and Prevention, ignoring complaints that his work on high-profile vaccine research more than 20 years ago was flawed.
  Kaiser Health News, March 2018
• Participants in Rogue Herpes Vaccine Research Take Legal Action Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
  Kaiser Health News, March 2018
• US Adult Obesity Rate Jumped Over Last 20 Years In the latest report from the National Center for Health Statistics, diagnosed diabetes increased from 5.1% to 9.5% of the population from 1997 to 2017. Smoking rates have taken a sharp drop.
  Medscape Medical News, March 2018
• Flu Shot Cuts Risk for Death by Half in Heart Failure Results of a meta-analysis support wider use of the influenza vaccine in patients with heart failure, researchers say.
  Medscape Medical News, March 2018
• Tenofovir Fails to Add Extra Hepatitis B Protection for Vaccinated Newborns Adding tenofovir disoproxil fumarate (TDF) to an aggressive treatment strategy fails to give extra protection to newborns at risk for contracting hepatitis B virus (HBV) from their infected mothers, according to a study at 17 public hospitals in Thailand.
  Reuters Health Information, March 2018